Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / NEXTBio Capital Management LP
Form 13F · Q2 2026

NEXTBio Capital Management LP

CIK 2038158Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$217M
Reported book value
22
Positions
3
Quarters on record
Top 50
Positions

NEXTBio Capital Management LP — holdings

Top 22 positions of 22, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PTGX Protagonist Therapeutics Inc219,333−4.5%$27M12.4%
2STTK Shattuck Labs Inc3.7M+18.3%$26M11.9%
3CMPS Compass Pathways Plc1.8M−12.2%$25M11.6%
4GPCR Structure Therapeutics Inc312,496+134.5%$17M7.7%
5VOR Vor Biopharma Inc889,164−11.1%$16M7.5%
6RYTM Rhythm Pharmaceuticals Inc131,758+4.5%$15M6.7%
7PVLA Palvella Therapeutics Inc Ne89,909+8.7%$14M6.3%
8XENE Xenon Pharmaceuticals Inc183,225+0.0%$11M5.1%
9ZBIO Zenas Biopharma Inc426,736+0.0%$11M5.0%
10ORIC Oric Pharmaceuticals Inc706,124+34.9%$8M3.5%
11IVA Inventiva Sa1.8M+34.1%$7M3.1%
12CBIO Crescent Biopharma Inc.372,856+0.0%$7M3.1%
13PCVX Vaxcyte Inc107,223+12.6%$6M2.9%
14COGT Cogent Biosciences Inc131,075−0.1%$5M2.3%
15VSTM Verastem Inc1.3M+0.0%$5M2.3%
16IRON Disc Medicine Inc52,655+0.0%$4M1.8%
17PHVS Pharvaris N V108,055—$4M1.7%
18ZLAB Zai Lab Ltd183,362+0.0%$3M1.6%
19BIOA Bioage Labs Inc100,732—$2M1.1%
20LBRX Lb Pharmaceuticals Inc68,249—$2M1.0%
21EVMN Evommune Inc119,063−35.3%$2M0.7%
22ACET Adicet Bio Inc157,827+0.0%$1M0.6%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.